Research Grade Felvizumab
Product Sizes
100 ug
£341.00
DVV02804-100UG
1 mg
£905.00
DVV02804-1MG
5 mg
£2665.00
DVV02804-5MG
About this Product
- SKU:
- DVV02804
- Additional Names:
- SB 209763, HuRSV19VHFNS/VK, RSHZ19 monoclonal antibody, SB 209763, CAS: 167747-20-8
- Buffer:
- 0.01M PBS, pH 7.4.
- translate.label.attr.clone:
- Felvizumab
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Felvizumab [HuRSV19VHFNS/VK, RSHZ19, RSV monoclonal antibody, SB 209763] is a humanised monoclonal antibody (IgG1) prepared by the humanization of an F protein-specific murine MAb. In in vitro studies, palivizumab, another humanized Mab specific for the F protein of RSV, was 4 to 5-fold more potent than felvizumab in neutralising RSV (Scott, 1999). RSHZ19 (Felvizumab) RSV This antibody was
- Host:
- Human
- Immunogen:
- F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
- Isotype:
- IgG1, kappa
- Physical State:
- Liquid
- Purity:
- >95%
- Purification:
- Protein A/G purified from cell culture supernatant.
- Reactivities:
- Virus
- Shipping Conditions:
- Blue Ice
- Source:
- XtenCHO
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystem
- Type:
- Antibody: Recombinant Antibodies
- Manufacturer's Data Sheet:642.html
